The European Commission has expanded approval for Pfizer's hemophilia drug HYMPAVZI (marstacimab) to cover adolescents and adults with hemophilia A…
Read More

The European Commission has expanded approval for Pfizer's hemophilia drug HYMPAVZI (marstacimab) to cover adolescents and adults with hemophilia A…
Read MoreDDC (NYSE American: DDC) executed a two-month reset in October–November 2025 combining…
Read More